Will Medicare Price Negotiation Delay Cancer-Drug Launches?
N Engl J Med
; 389(17): 1546-1548, 2023 Oct 26.
Article
in En
| MEDLINE
| ID: mdl-37819215
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
Database:
MEDLINE
Main subject:
Medicare
/
Drug Costs
/
Drug Development
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Health_economic_evaluation
Limits:
Aged
/
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
N Engl J Med
Year:
2023
Document type:
Article